The Honda Racing Corporation (HRC) confirmed that Spanish rider Joan Mir will not line up for the upcoming Austrian Grand Prix at the Red Bull Ring. The decision follows a series of medical examinations carried out after Mir retired early from the San Marino round at Misano. Blood analysis conducted in Barcelona showed irregular parameters, and without a definitive diagnosis, his medical team advised a period of rest and further testing.
Mir, the 2020 MotoGP world champion, entered the Misano sprint race despite complaining of persistent headaches and a noticeable drop in energy. He managed a twentieth-place finish in the sprint, but the symptoms lingered into the Sunday race. After completing only five laps of the main event, Mir pulled the plug, citing an inability to continue at a competitive level. Subsequent investigations in Catalonia identified the atypical blood results that have now sidelined him for the Spielberg weekend.
Honda’s immediate response and rider substitution
In the wake of Mir’s withdrawal, HRC announced that its test and development rider Takaaki Nakagami will take the vacant seat alongside Luca Marini for the Austrian round. Nakagami, a Japanese rider who last appeared in a MotoGP race at Motegi in the 2025 season, has been focusing on the development of Honda’s 850 cc/Pirelli prototype throughout the year. Fresh from a private test session at Mugello, he will now ride the factory-spec Honda RC213V Castrol equipped with Michelin tyres.
“I arrive in Austria straight from a Mugello test, but we have been experimenting with a variety of machines,” Nakagami explained in a post-test interview. “This weekend is about regaining full speed on the RC213V and the Michelin compounds ahead of my wildcard at Motegi. We’ll also try a few setups that the team doesn’t usually run, so we can gather extra data for future development.” His presence not only fills the grid vacancy but also offers Honda valuable on-track feedback ahead of the crucial Japanese Grand Prix.
Implications for Honda’s championship campaign
The unexpected absence of Mir, who currently rides the #36 bike, creates a short-term gap in Honda’s rider lineup. While his replacement ensures that the team still fields a full roster for the Red Bull Ring, the broader impact hinges on Mir’s recovery timeline. Honda officials indicated that the focus remains on Mir’s health, with a tentative target of returning for the Japanese Grand Prix, Honda’s home event, which follows the Austrian race.
From a strategic standpoint, the Austrian weekend now serves a dual purpose: it offers Nakagami a rare opportunity to test the 1,000 cc engine in race conditions, and it provides Honda engineers with fresh data on tyre performance, bike ergonomics, and aerodynamic tweaks under Spielberg’s fast-flowing layout. Such insights could prove decisive as the championship enters its final stages, where marginal gains often separate podium finishers from the rest of the field.
Outlook for Joan Mir and the upcoming races
Mir’s medical team has ordered additional investigations to pinpoint the cause of the abnormal blood markers. In the meantime, the Spanish rider is advised to focus on recovery, nutrition, and low-impact conditioning. Should the tests confirm a manageable issue, Honda hopes to see Mir back on the track for the Motegi showdown, where he will also have the chance to gauge his fitness against his rivals in a familiar environment.
Fans and pundits alike will be watching closely for updates from Barcelona’s medical facilities. Until a clear diagnosis emerges, the priority remains Mir’s long-term well-being, reinforcing the sport’s emphasis on rider safety over short-term competition goals.
